Focusing on the interface of medicinal chemistry, pharmacology, and computational science, the book examines therapeutic strategies targeting diseases such as leishmaniasis, Chagas disease, malaria, schistosomiasis, dengue, Zika virus, tuberculosis, and fascioliasis. It highlights how structure–activity relationships (SAR), molecular modeling, and synthetic chemistry are driving the development of effective and safer drug candidates.
Designed for researchers, medicinal chemists, pharmacologists, and professionals in the pharmaceutical sciences, the book provides practical insights into compound design, optimization, and preclinical assessment, along with future directions in precision drug development for NTDs.
Key Features:
Comprehensive overview of medicinal chemistry and target-based drug design
Coverage of both parasitic and viral diseases with global health relevance
Discussion of structure–activity relationships and emerging therapeutic compounds
Integration of synthetic and computational approaches to drug discovery
About the Editors:
Professor Igor José dos Santos Nascimento holds a Ph.D. in Chemistry from the Federal University of Alagoas, Brazil, and completed a postdoctoral fellowship at Universidade NOVA de Lisboa, Portugal. His research expertise spans medicinal chemistry, organic synthesis, and computational drug design, with more than 55 articles and 15 book chapters published.
Professor Ricardo Olímpio de Moura earned his Ph.D. in Biological Sciences from the Federal University of Pernambuco, Brazil, and conducted research at Université Louis Pasteur, France. He specializes in organic synthesis and medicinal chemistry, focusing on the development of antiparasitic, antitumor, and anti-inflammatory compounds, and has authored over 90 scientific papers.
Learn more about this book here: http://bit.ly/4qpKZI2
For media inquiries, review copies, or interviews, please contact Bentham Science Publishers.